Speaker illustration

undefined undefined undefined

Reduction of tissue sodium content by SGLT-2-inhibition with dapagliflozin

Event: ESC Congress 2017

Topic: Treatment of hypertension

Session: Innovations in hypertension management and devices

Thumbnail

ESC 365 is supported by